Account
Articles
07.06.2022
EU Joint HTA: What’s going on and what does it m...

EUnetHTA and the EU Joint HTA Process Originally set up in 2006, EUnetHTA was established to facilit...

Read more
News
18.05.2022
PMA Insights: Week 20

We summarise key pharmaceutical, pricing and market access insights that are worth reading about thi...

Read more
Insider Insights
15.03.2022
NICE presents three-year international strategy

Two NICE teams (NICE International and the Science Policy and Research Programme) will act as key en...

Read more
Insider Insights
28.02.2022
UK first rare disease action plan

On 28th February 2022, Health and Social Care Secretary Sajid Javid launched England’s first Rare...

Read more
Articles
24.02.2022
Patient reported outcomes

This educational blog explores what PROs are, explains why they of growing importance in the digital...

Read more
Articles
07.02.2022
Advanced therapy medicinal product withdrawals

Advanced therapy medicinal products (ATMPs) are medicinal products for human use that are based on l...

Read more
Insider Insights
01.02.2022
Committee recommends rejecting Rx to non-Rx reques

The committee’s recommendations are forwarded to the Federal Ministry of Health for consideration.

Read more
Articles
01.02.2022
Changes to NICE's health technology evaluation

This reforms have been welcomed by the industry as they should support faster access to medicines as...

Read more
Insider Insights
01.02.2022
Proposals aimed at building together our future

The association proposes concentrating efforts around four primary objectives.

Read more
Insider Insights
01.02.2022
Orphan drugs undergo early benefit assessment

According to the Institute for Quality and Efficiency in Health Care orphan drugs should undergo ear...

Read more

Stay in the know, subscribe to our newsletter

Be the first to receive exclusive content on the latest from the pharmaceutical and market access sector.